Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fong-Lin Jang

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Medical Sciences|February 11, 2020
Alterations of plasma cytokine biomarkers for identifying age at onset of schizophrenia with neurological soft signsJia-Yun Liu, Han-Yu Chen, Jin-Jia Lin, et al.
Journal of Clinical Medicine|September 14, 2019
Risk Model Assessment in Early-Onset and Adult-Onset Schizophrenia Using Neurological Soft SignsBao-Yu Chen, I-Ning Tsai, Jin-Jia Lin, et al.
Pain Physician|September 23, 2021
Chronic Pain Increases the Risk of Dementia: A Nationwide Population-Based Cohort StudyPei-Hsin Kao, Fong-Lin Jang, Chung-Han Ho, et al.
Journal of Psychiatric Research|November 28, 2022
DNA methylation signature aberration as potential biomarkers in treatment-resistant schizophrenia: Constructing a methylation risk score using a machine learning methodAndrew Ke-Ming Lu, Jin-Jia Lin, Huai-Hsuan Tseng, et al.
Brain, Behavior, and Immunity|August 1, 2022
Profiling antibody signature of schizophrenia by Escherichia coli proteome microarraysBao-Yu Chen, Chu-Chun Hsu, You-Zuo Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 29, 2025
Profiling small extracellular vesicles microRNAs and their expressions in EVs-depleted plasma as biomarkers for distinguishing schizophreniaBao-Yu Chen, Jin-Jia Lin, Huai-Hsuan Tseng, et al.
Schizophrenia Research|January 29, 2026
Small EVs miRNA profiles and their expressions in EVs-depleted plasma as an optimal combination panel for treatment-resistant schizophreniaBao-Yu Chen, Jin-Jia Lin, Huai-Hsuan Tseng, et al.
Schizophrenia Research|April 12, 2025
Developing a risk assessment model for treatment-resistant schizophrenia: The role of niacin receptor GPR109A and prostaglandin receptors DP<sub>1</sub>, EP<sub>2</sub>, and EP<sub>4</sub> in the niacin-induced flushing pathwayChi-Wei Chiu, Bao-Yu Chen, Jin-Jia Lin, et al.
Schizophrenia Bulletin|April 3, 2025
Exploring Primary and Interaction Effects of Minor Physical Anomalies: Development and Validation of Prediction Models Using Explainable Machine Learning Algorithms for Early-Onset SchizophreniaChih-Wei Lin, Jin-Jia Lin, Huai-Hsuan Tseng, et al.
Journal of Psychiatric Research|December 17, 2014
SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese populationYi-Wei Yeh, Cheng-Jueng Chen, Fong-Lin Jang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Medical Sciences|February 11, 2020
Alterations of plasma cytokine biomarkers for identifying age at onset of schizophrenia with neurological soft signsJia-Yun Liu, Han-Yu Chen, Jin-Jia Lin, et al.
Journal of Clinical Medicine|September 14, 2019
Risk Model Assessment in Early-Onset and Adult-Onset Schizophrenia Using Neurological Soft SignsBao-Yu Chen, I-Ning Tsai, Jin-Jia Lin, et al.
Pain Physician|September 23, 2021
Chronic Pain Increases the Risk of Dementia: A Nationwide Population-Based Cohort StudyPei-Hsin Kao, Fong-Lin Jang, Chung-Han Ho, et al.
Journal of Psychiatric Research|November 28, 2022
DNA methylation signature aberration as potential biomarkers in treatment-resistant schizophrenia: Constructing a methylation risk score using a machine learning methodAndrew Ke-Ming Lu, Jin-Jia Lin, Huai-Hsuan Tseng, et al.
Brain, Behavior, and Immunity|August 1, 2022
Profiling antibody signature of schizophrenia by Escherichia coli proteome microarraysBao-Yu Chen, Chu-Chun Hsu, You-Zuo Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 29, 2025
Profiling small extracellular vesicles microRNAs and their expressions in EVs-depleted plasma as biomarkers for distinguishing schizophreniaBao-Yu Chen, Jin-Jia Lin, Huai-Hsuan Tseng, et al.
Schizophrenia Research|January 29, 2026
Small EVs miRNA profiles and their expressions in EVs-depleted plasma as an optimal combination panel for treatment-resistant schizophreniaBao-Yu Chen, Jin-Jia Lin, Huai-Hsuan Tseng, et al.
Schizophrenia Research|April 12, 2025
Developing a risk assessment model for treatment-resistant schizophrenia: The role of niacin receptor GPR109A and prostaglandin receptors DP<sub>1</sub>, EP<sub>2</sub>, and EP<sub>4</sub> in the niacin-induced flushing pathwayChi-Wei Chiu, Bao-Yu Chen, Jin-Jia Lin, et al.
Schizophrenia Bulletin|April 3, 2025
Exploring Primary and Interaction Effects of Minor Physical Anomalies: Development and Validation of Prediction Models Using Explainable Machine Learning Algorithms for Early-Onset SchizophreniaChih-Wei Lin, Jin-Jia Lin, Huai-Hsuan Tseng, et al.
Journal of Psychiatric Research|December 17, 2014
SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese populationYi-Wei Yeh, Cheng-Jueng Chen, Fong-Lin Jang, et al.
Pageof 3